Page 89 - Revista Argentina de Transfusión 2-2019

52. Fibach E, Rachmilewitz EA. Pathophysiology and treatment of 58. Chou ST, Liem RI, Thompson AA: Challenges of alloimmunization
patients with betathalassemia an update. F1000Res. 2017 Dec in patients with haemoglobinopathies. Br J Haematol 2012;
20;6:2156.Review 159:394–404
53. Taher AT, Radwan A, Viprakasit V.When to consider transfusion 59. Thompson AA, Cunningham MJ, Singer ST, et al.: Red cell
therapy for patients with non-transfusion-dependent alloimmunization in a diverse population of transfused patients
thalassaemia.Vox Sang. 2015 Jan;108(1):1Review with thalassaemia. Br J Haematol 2011;153:121–128
54. Taher A, Vichinsky E, Musallam KM, et al.: Guidelines for the 60. Vichinsky E, Neumayr L, Trimble S, et al.: Transfusion compli-
Management of Non Transfusion Dependent Thalassaemia cations in thalassemia patients: a report from the Centers for
(NTDT). TIF Publication No. 19. Nicosia, Cyprus, Thalassaemia Disease Control and Prevention. Transfusion 2014; 54:972–
International Federation, 2013 981
55. Taher AT, Musallam KM, Karimi M, et al.: Overview on prac- 61. Thompson AA, Cunningham MJ, Singer ST, Neufeld EJ, Vichinsky
tices in thalassemia intermedia management aiming for low- E, Yamashita R, Giardina P, Kim HY, Trachtenberg F, Kwiatkowski
ering complication rates across a region of endemicity: the JL; Thalassemia Clinical Research Network Investigators. Red
OPTIMAL CARE study. Blood 2010; 115:1886– 1892 cell alloimmunization in a diverse population of transfused
56. Singer ST, Kuypers FA, Styles L, et al.: Pulmonary hypertension patients with thalassaemia. Br J Haematol. 2011 Apr;153(1):121-
in thalassemia: association with platelet activation and 8.
hypercoagulable state. Am J Hematol 2006; 81:670–675 62. Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guide-
57. Kosaryan M, Mahdavi MR, Roshan P, et al.: Prevalence of lines for the Management of Transfusion Dependent Thalas-
alloimmunisation in patients with beta thalassaemia major. saemia (TDT). 3rd edition. Nicosia (CY): Thalassaemia Interna-
Blood Transfus 2012; 10:396– 397 tional Federation; 2014

Curso AAHITC de Médico Especialista en Hemoterapia Vol. XLV / N° 2 / 2019 Asociación Argentina Pág. 173
e Inmunohematología. Formación en Medicina Págs. 149 / 173 de Hemoterapia,
Transfusional y Terapia Celular. Inmunohematología
Terapia transfusional en anemias hemolíticas con- y Terapia Celular
génitas.